Cargando…
Gene therapy for haemophilia
The ultimate goal of gene therapy is the replacement of a defective gene sequence with a corrected version to eliminate disease for the lifetime of the patient. This challenging task is not yet accomplished, however significant progress is evident. An initial spate of clinical trials attempting the...
Autores principales: | Murphy, Samuel L, High, Katherine A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2408641/ https://www.ncbi.nlm.nih.gov/pubmed/18275425 http://dx.doi.org/10.1111/j.1365-2141.2007.06942.x |
Ejemplares similares
-
Gene therapy in haemophilia: literature review and regional perspectives for Turkey
por: Kavaklı, Kaan, et al.
Publicado: (2022) -
How to translate and implement the current science of gene therapy into haemophilia care?
por: Hermans, Cedric, et al.
Publicado: (2023) -
Improving patient informed consent for haemophilia gene therapy: the
case for change
por: Woollard, Laurence, et al.
Publicado: (2021) -
Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines
por: Petkovic, Madison J., et al.
Publicado: (2022) -
Living with Haemophilia
por: Laffan, Mike
Publicado: (1995)